Nathalie Cheron

1.1k total citations
9 papers, 315 citations indexed

About

Nathalie Cheron is a scholar working on Hematology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nathalie Cheron has authored 9 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Genetics and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nathalie Cheron's work include Chronic Lymphocytic Leukemia Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Nathalie Cheron is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). Nathalie Cheron collaborates with scholars based in France and Belgium. Nathalie Cheron's co-authors include M Monconduit, Christian Bastard, Christophe Louvet, N Smadja, F Isnard, Christophe Fermé, F Berger, Pauline Brice, Oumédaly Reman and Jean Gabarre and has published in prestigious journals such as Blood, Annals of Oncology and Leukemia.

In The Last Decade

Nathalie Cheron

7 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie Cheron France 5 180 113 112 102 97 9 315
J García Laraña Spain 10 189 1.1× 74 0.7× 117 1.0× 172 1.7× 72 0.7× 13 384
Agnès Charpentier France 7 161 0.9× 104 0.9× 45 0.4× 59 0.6× 145 1.5× 13 322
Carlos E. Bueso-Ramos United States 6 149 0.8× 109 1.0× 73 0.7× 147 1.4× 171 1.8× 12 334
C. Tsatalas Greece 8 122 0.7× 32 0.3× 84 0.8× 125 1.2× 77 0.8× 10 266
Marjan Ertault France 9 63 0.3× 43 0.4× 88 0.8× 222 2.2× 84 0.9× 14 306
Esperanza Tuset Spain 10 88 0.5× 30 0.3× 56 0.5× 77 0.8× 113 1.2× 13 244
Claudia Minotto Italy 9 92 0.5× 56 0.5× 62 0.6× 110 1.1× 122 1.3× 14 252
F. Dreyfus France 8 326 1.8× 59 0.5× 108 1.0× 68 0.7× 114 1.2× 18 453
Delia Rota‐Scalabrini Italy 8 112 0.6× 85 0.8× 133 1.2× 118 1.2× 76 0.8× 12 252

Countries citing papers authored by Nathalie Cheron

Since Specialization
Citations

This map shows the geographic impact of Nathalie Cheron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Cheron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Cheron more than expected).

Fields of papers citing papers by Nathalie Cheron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie Cheron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Cheron. The network helps show where Nathalie Cheron may publish in the future.

Co-authorship network of co-authors of Nathalie Cheron

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Cheron. A scholar is included among the top collaborators of Nathalie Cheron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Cheron. Nathalie Cheron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
3.
Fuks, David, Éric Bartoli, Richard Delcenserie, et al.. (2009). Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice. Journal of Gastroenterology and Hepatology. 24(11). 1745–1752. 27 indexed citations
4.
Saliba, Faouzi, Nathalie Cheron, Anne Renault, et al.. (2006). 123 A prospective French National Survey to assess renal safety of amphotericin B lipid complex and liposomal amphotericin B. International Journal of Infectious Diseases. 10. S68–S69. 4 indexed citations
5.
Gardembas, Martine, Philippe Rousselot, Michel Tulliez, et al.. (2003). Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase. Blood. 102(13). 4298–4305. 44 indexed citations
6.
Isnard, F, Michel Guiguet, Patricia Zunic, et al.. (2001). Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution. Bone Marrow Transplantation. 27(10). 1045–1052. 5 indexed citations
7.
Smadja, N, F Isnard, Christophe Louvet, et al.. (1998). Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases. Leukemia. 12(6). 960–969. 133 indexed citations
8.
Fermé, Christophe, Y Bastion, Éric Lepage, et al.. (1995). The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin’s disease. Annals of Oncology. 6(6). 543–549. 100 indexed citations
9.
Fenaux, Pierre, Bernard G. Jaar, J.P. Laporte, et al.. (1991). Recombinant human erythropoietin (rh Epo): A possible treatment for the anemia of myelodysplastic syndromes (MDS). Leukemia Research. 15. 32–32. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026